Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4278-4282, October 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levin, D. B.
Right arrow Articles by Kusser, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, D. B.
Right arrow Articles by Kusser, W.

Detection of p53 Mutations in Benign and Dysplastic Nevi1

David B. Levin2, Kenneth Wilson, Giovana Valadares de Amorim, Jane Webber, Patrick Kenny and Wolfgang Kusser

Department of Biology, Centre for Environmental Health, University of Victoria, Victoria [D. B. L., G. V. d. A., J. W., W. K.]; British Columbia Cancer Agency, Victoria [K. W.]; and University of British Columbia, Vancouver [K. W., P. K.], British Columbia, Canada

We have examined melanocytic cells derived directly from fresh biopsy tissue for the presence of p53 mutations. Using selective media that permits growth of melanocytes and inhibits growth of fibroblasts and keratinocytes, we established short-term, primary cultures of melanocytes from skin biopsies of common acquired nevi, dysplastic nevi, and from metastatic melanoma. Using PCR-single-stranded conformational polymorphism analysis, we have detected p53 mutations in 2 of 11 benign compound nevi and 2 of 5 dysplastic nevi. All nevi positive for p53 mutations were derived from patients who previously had cutaneous moles and three of the four had a family and/or personal history of melanoma.

1 Supported by the Natural Sciences and Engineering Council of Canada (NSERC) and Kabi Pharmacia by their contributions to the NSERC-Industrial Research partnership grant.

2 To whom requests for reprints should be addressed, at Department of Biology, Centre for Environmental Health, University of Victoria, P.O. Box 1700, Victoria, British Columbia, V8W 2Y2 Canada.

Received 7/31/95. Accepted 8/18/95.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
M. R. A.-E. Hussein and G. S. Wood
Molecular Aspects of Melanocytic Dysplastic Nevi
J. Mol. Diagn., May 1, 2002; 4(2): 71 - 80.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
T. Haapajärvi, K. Pitkänen, and M. Laiho
Human Melanoma Cell Line UV Responses Show Independency of p53 Function
Cell Growth Differ., March 1, 1999; 10(3): 163 - 171.
[Abstract] [Full Text]


Home page
INT J SURG PATHOLHome page
Z. Kaleem, A. C. Lind, P. A. Humphrey, P. E. Swanson, R. H. Sueper, J. H. Ritter, and M. R. Wick
Immunohistologic Evaluation of Putatively Mutant p53 Protein in Cutaneous Melanocytic Neoplasms: A Study of 256 Cases
International Journal of Surgical Pathology, April 1, 1998; 6(2): 73 - 79.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.